A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice. [electronic resource]
- Cancer research Jan 1997
- 162-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0008-5472
Animals Antineoplastic Agents--therapeutic use Carcinoma, Squamous Cell--drug therapy Drug Screening Assays, Antitumor Humans Mice Mice, Nude Mouth Neoplasms--drug therapy Receptors, Retinoic Acid--agonists Retinoids--therapeutic use Transplantation, Heterologous